Forensic Genomics Market Size, Share and Growth Outlook, 2026

Forensic Genomics Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Forensic Genomics Market size is forecast to increase from $786.55 Million in 2026 to $2439.75 Million in 2034 at a CAGR of 15.2% between 2026 and 2034.

The Forensic Genomics market report provides detailed analysis and outlook of Forensic Genomics segments including By Product (Analyzers & Sequencers, Kits & Consumables, Software & Services), By Method (Capillary Electrophoresis, Next-Generation Sequencing, PCR Amplification, Microarray), By Application (Criminal Testing, Paternity & Familial Testing, Disaster Victim Identification, Human Identification, Missing Person Identification), By End User (Forensic Laboratories, Law Enforcement Agencies, Research & Academic Institutes, Government Agencies) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Forensic Genomics Industry Overview

Advanced Genomic Technologies Transforming Forensic Investigations

The forensic genomics industry is undergoing significant advancement as law enforcement agencies, forensic laboratories, and research institutions increasingly adopt next-generation genetic technologies to improve human identification, criminal investigations, and disaster victim recovery efforts. The growing demand for higher analytical sensitivity, improved data resolution, and enhanced capabilities for degraded biological samples is accelerating the transition from traditional forensic DNA methods toward advanced genomic sequencing platforms. Developments in single-nucleotide polymorphism analysis, artificial intelligence, and high-throughput sequencing are enabling forensic experts to generate more comprehensive genetic profiles while supporting increasingly complex investigative and legal requirements.

High-Throughput Sequencing Expanding Disaster Victim Identification Capabilities

Forensic laboratories are increasingly optimizing genomic technologies to support large-scale identification programs. Researchers recently developed an enhanced workflow for the ForenSeq® Kintelligence Kit specifically designed for high-throughput disaster victim identification applications. Through modifications to sequencing multiplex architecture, the platform can process up to 12 post-mortem and 32 ante-mortem samples simultaneously while analyzing more than 10,230 forensically relevant single-nucleotide polymorphisms. The optimized system is capable of generating reliable genetic information from highly degraded skeletal and dental remains, significantly strengthening forensic identification capabilities in mass casualty events and complex humanitarian investigations.

Next-Generation Sequencing Replacing Conventional STR Analysis

The industry is witnessing a broad migration from traditional short tandem repeat testing toward next-generation sequencing technologies that provide greater analytical depth. State forensic laboratories are increasingly adopting advanced systems such as Illumina’s MiSeq FGx platform, enabling simultaneous analysis of autosomal STRs, Y-STRs, X-STRs, and mitochondrial DNA markers from a single biological specimen. This comprehensive approach maximizes information recovery from low-template and highly degraded evidence samples while improving efficiency and investigative accuracy. The ability to generate multiple genetic marker profiles within a single workflow is becoming a critical advantage for modern forensic genomics laboratories.

Artificial Intelligence and Genetic Genealogy Enhancing Human Identification

Emerging technologies are further expanding the capabilities of forensic genomics. Investigative genetic genealogy continues to gain importance as a powerful tool for solving cold cases and identifying unknown individuals through large-scale SNP analysis and advanced sequencing techniques. Collaborative initiatives such as Forensic DNA Dialogues are helping translate scientific advancements into practical forensic applications. Simultaneously, researchers are validating convolutional neural network-based regression models for age and sex estimation from skeletal remains, providing statistically robust tools for forensic identification. In parallel, forensic toxicology researchers are introducing standardized frameworks such as the Toxicological Significance Score to improve interpretation of toxicological findings and strengthen the scientific defensibility of expert testimony. These innovations demonstrate the growing integration of genomics, artificial intelligence, and data science within contemporary forensic investigations.

Forensic Genomics Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Forensic Genomics market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Illumina, Inc., Thermo Fisher Scientific, Promega Corporation, QIAGEN N.V., Merck KGaA, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific, LGC Limited, Bode Cellmark Forensics, Inc.. The Forensic Genomics market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Forensic Genomics industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Forensic Genomics Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Forensic Genomics companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Forensic Genomics markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Forensic Genomics Market Competitive Benchmarking and Company Analysis

Leading companies in Forensic Genomics industry include- Illumina, Inc., Thermo Fisher Scientific, Promega Corporation, QIAGEN N.V., Merck KGaA, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific, LGC Limited, Bode Cellmark Forensics, Inc.. The Forensic Genomics market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Forensic Genomics Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Forensic Genomics market remains one of the strongest-performing segments in the country.
The US Forensic Genomics Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Forensic Genomics market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Forensic Genomics industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Forensic Genomics markets

Canada's strong Forensic Genomics sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Forensic Genomics market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Forensic Genomics Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Forensic Genomics market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Forensic Genomics population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Forensic Genomics industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Forensic Genomics market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Forensic Genomics sales through 2034

France Forensic Genomics companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Forensic Genomics Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Forensic Genomics distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Forensic Genomics Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Forensic Genomics market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Forensic Genomics industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Forensic Genomics industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Forensic Genomics Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Forensic Genomics market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Forensic Genomics market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Forensic Genomics Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Forensic Genomics Market Segmentation

By Product
Analyzers & Sequencers
Kits & Consumables
Software & Services
By Method
Capillary Electrophoresis
Next-Generation Sequencing
PCR Amplification
Microarray
By Application
Criminal Testing
Paternity & Familial Testing
Disaster Victim Identification
Human Identification
Missing Person Identification
By End User
Forensic Laboratories
Law Enforcement Agencies
Research & Academic Institutes
Government Agencies

Top Companies in Forensic Genomics Industry

Illumina, Inc.
Thermo Fisher Scientific
Promega Corporation
QIAGEN N.V.
Merck KGaA
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Eurofins Scientific
LGC Limited
Bode Cellmark Forensics, Inc.

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025